Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Item No. 39072

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Seamlessly bridge your LNP discovery journey from RUO to bulk GLP-tox and GMP excipient-grade material.
Explore CGMP Lipid ServicesPAMAM dendrimer G2.0 amine (PAMAM G2.0) is a polyamidoamine (PAMAM) dendrimer with amine termini.1 It is approximately 29 Å in diameter and has 16 surface groups. PAMAM G2.0 (15 mg/ml) in combination with erythromycin (Item No. 16486) enhances the solubility and antibacterial activity of erythromycin against S. aureus.2 It increases the cell growth rate of HEK293T and HeLa cells when used at concentrations ranging from 100 to 500 nM but is cytotoxic to the same cells when used at concentrations greater than or equal to 700 nM.3 In vivo, PAMAM G2.0 when administered in combination with fluorescein isothiocyanate-labeled dextran enhances its nasal absorption in rats.4
WARNING This product is not for human or veterinary use.
1. Developmental toxicity of low generation PAMAM dendrimers in zebrafish. Toxicol. Appl. Pharmacol. 225(1), 70-79 (2007).
2. The effect of PAMAM dendrimers on the antibacterial activity of antibiotics with different water solubility. Molecules 18(7), 8607-8617 (2013).
3. Mechanistic insight into cell growth, internalization, and cytotoxicity of PAMAM dendrimers. Biomacromolecules 11(2), 382-389 (2010).
4. Effects of polyamidoamine (PAMAM) dendrimers on the nasal absorption of poorly absorbable drugs in rats. Int. J. Pharm. 393(1-2), 244-252 (2010).